Erythropoiesis-stimulating agents in sickle cell anaemia

被引：14
|
作者：
Han, Jin [1 ,2 ,3 ]
Zhou, Jifang [3 ]
Kondragunta, Vinod [1 ]
Zhang, Xu [1 ]
Molokie, Robert E. [1 ]
Gowhari, Michel [1 ]
Hassan, Johara [1 ]
Jain, Shivi [1 ]
Calip, Gregory S. [3 ]
Gordeuk, Victor R. [1 ]
Saraf, Santosh L. [1 ]
机构：
[1] Univ Illinois, Dept Med, Ctr Comprehens Sickle Cell, Div Hematol & Oncol, Chicago, IL 60607 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[3] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷 / 04期
基金：
美国国家卫生研究院;
关键词：
sickle cell anaemia; erythropoietin; darbepoetin; erythropoiesis-stimulating agents; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RENAL-FAILURE; HYDROXYUREA;
D O I：
10.1111/bjh.14846
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：602 / 605
页数：4
相关论文
共 50 条
  • [21] Erythropoiesis-stimulating agents and thrombotic events in dialysis patients
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1081 - 1086
  • [22] Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
    Koulouridis, Ioannis
    Alfayez, Mansour
    Trikalinos, Thomas A.
    Balk, Ethan M.
    Jaber, Bertrand L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (01) : 44 - 56
  • [23] The Use of Erythropoiesis-Stimulating Agents in the Intensive Care Unit
    Piagnerelli, Michael
    Vincent, Jean-Louis
    CRITICAL CARE CLINICS, 2012, 28 (03) : 345 - +
  • [24] Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
    Carrero, Juan Jesus
    Barany, Peter
    Yilmaz, Mahmut Ilker
    Qureshi, Abdul Rashid
    Sonmez, Alper
    Heimburger, Olof
    Ozgurtas, Tanez
    Yenicesu, Mujdat
    Lindholm, Bengt
    Stenvinkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) : 709 - 715
  • [25] An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (08) : 1021 - 1030
  • [26] Correcting Anemia in Heart Failure: The Efficacy and Safety of Erythropoiesis-Stimulating Agents
    Lawler, Patrick R.
    Filion, Kristian B.
    Eisenberg, Mark J.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : 649 - 658
  • [27] End of an era for erythropoiesis-stimulating agents in oncology
    Schoen, Martin W.
    Hoque, Shamia
    Witherspoon, Bartlett J.
    Schooley, Benjamin
    Sartor, Oliver
    Yang, Y. Tony
    Yarnold, Paul R.
    Knopf, Kevin B.
    Hrushesky, William J. M.
    Dickson, Michael
    Chen, Brian J.
    Nabhan, Chadi
    Bennett, Charles L.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (10) : 2829 - 2835
  • [28] Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis
    Marti-Carvajal, Arturo J.
    Agreda-Perez, Luis H.
    Sola, Ivan
    Simancas-Racines, Daniel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [29] Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
    Doshi, Sameer
    Krzyzanski, Wojciech
    Yue, Susan
    Elliott, Steven
    Chow, Andrew
    Jose Perez-Ruixo, Juan
    CLINICAL PHARMACOKINETICS, 2013, 52 (12) : 1063 - 1083
  • [30] Erythropoiesis-Stimulating Agents and Cancer: Myth or Truth
    Choi, Michael J.
    Yee, Jerry
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 221 - 224
12345